Yongping Xue
Overview
Explore the profile of Yongping Xue including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
250
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li W, Xue Y, Gong Z
J Plast Reconstr Aesthet Surg
. 2024 Dec;
101:97-98.
PMID: 39721286
No abstract available.
2.
3.
Qin Y, Han H, Xue Y, Wu C, Wei X, Liu Y, et al.
Int Braz J Urol
. 2020 Jul;
46(5):754-771.
PMID: 32648416
Purpose: To make a further evaluation of perioperative outcomes between the robot-assisted radical prostatectomy (RARP) and open radical prostatectomy (ORP), we conducted a comparison and trend analysis by using the...
4.
Xiong Q, Liu A, Ren Q, Xue Y, Yu X, Ying Y, et al.
Cell Death Dis
. 2020 May;
11(5):366.
PMID: 32409654
Cisplatin-based chemotherapy is the first-line treatment for patients with advanced bladder cancer. However, as more than 50% of patients are ineligible for cisplatin-based chemotherapy, there is an urgent need to...
5.
Liu A, Xue Y, Liu F, Tan H, Xiong Q, Zeng S, et al.
Cancer Biomark
. 2019 Oct;
26(3):281-289.
PMID: 31594208
Background: Urothelial carcinoma of the bladder is a heterogeneous disease for which reliable prognostic molecular biomarkers have not been established. Objective: To investigate the prognostic value of tumor-associated trypsin inhibitor...
6.
Liu F, Liu A, Lu X, Zhang Z, Xue Y, Xu J, et al.
Cancer Med
. 2019 Oct;
8(16):6904-6914.
PMID: 31568654
Background: To examine the microbial profiles in parenchyma tissues in bladder cancer. Methods: Tissue samples of cancerous bladder mucosa were collected from patients diagnosed with bladder cancer (22 carcinoma tissues...
7.
Xue Y, Tong L, LiuAnwei Liu F, Liu A, Zeng S, Xiong Q, et al.
Oncol Rep
. 2019 Jun;
42(2):581-594.
PMID: 31233191
The present study aimed to explore the mechanism by which the immune landscape of the tumor microenvironment influences bladder cancer. CIBERSORT and ssGSEA analyses revealed that M2 macrophages accounted for...
8.
Zeng S, Liu A, Dai L, Yu X, Zhang Z, Xiong Q, et al.
BMC Cancer
. 2019 Jun;
19(1):604.
PMID: 31216997
Background: The prognosis of bladder urothelial carcinoma (BLCA) varies greatly among patients, and conventional pathological predictors are generally inadequate and often inaccurate to predict the heterogeneous behavior of BLCA. This...
9.
Yang Z, Liu A, Xiong Q, Xue Y, Liu F, Zeng S, et al.
J Cell Physiol
. 2019 Apr;
234(10):18763-18772.
PMID: 30953370
DNA methylation can regulate gene expression and is pivotal in the occurrence and development of bladder cancer. In this study, we analyzed whole-genome DNA methylation on the basis of data...
10.
Zeng S, Xue Y, Zhao J, Liu A, Zhang Z, Sun Y, et al.
Int Urol Nephrol
. 2018 Nov;
51(1):1-7.
PMID: 30465143
Background: This study aimed to systematically summarize and analyze the current evidence regarding the effect of total parenteral nutrition (TPN) versus early enteral nutrition (EEN) on postoperative outcomes of cystectomy....